In this article, we elucidate the pathophysiological role of SGLT2 in the nervous system, discuss the association between diabetes mellitus and diverse neurodegenerative diseases, and analyze current clinical investigations into SGLT2 inhibitors for neurodegenerative disorder management. Here, SLC5A2 is linked to neurodegenerative disease.